First Trust Large Cap Growth AlphaDEX Fund (FTC)

The First Trust Large Cap Growth AlphaDEX Fund is an exchange-traded fund that holds large-capitalisation growth companies, selected and weighted using First Trust’s proprietary AlphaDEX methodology rather than market capitalisation alone. It invests in established, profitable firms in sectors like technology and healthcare that show pricing strength and quality metrics.

Growth and value are often cast as enemies, but FTC’s strategy says the best growth stocks are those with value-like characteristics underneath.

The AlphaDEX approach to growth stock selection

FTC’s defining feature is its AlphaDEX methodology, a proprietary rule-based screening system that does not simply track the Russell 1000 Growth Index passively. Instead, it identifies large-cap growth companies that also possess certain value-type and quality characteristics — stocks that are expanding earnings while trading at reasonable valuations relative to those earnings, and that show financial stability and profitability. The approach appeals to investors who believe that true alpha (excess returns) comes from finding growth stocks trading at fairer prices, not from owning every growth-classified firm regardless of valuation or quality.

The AlphaDEX screen applies quantitative metrics to measure value characteristics (price relative to earnings and book value), momentum (recent price strength), and quality (profitability, capital efficiency, financial strength) within the Russell 1000 Growth universe. Companies that score highest across these dimensions are overweighted; those scoring lowest are underweighted or excluded. The result is a concentrated portfolio of approximately 350–450 stocks that differ materially from a passive growth index.

This methodology was developed at a time when the technology and growth sectors had become dominated by high-valuation, low-profitability names. AlphaDEX was designed to avoid the worst excesses while still capturing growth exposure. It succeeded in some periods and underperformed in others depending on whether the market rewarded quality-tilted growth or pure momentum.

Sector and thematic composition

Because AlphaDEX favours profitable growth with financial strength, the portfolio is heavily tilted toward established technology, healthcare, and consumer discretionary firms that generate strong cash flow and maintain conservative balance sheets. It is underweighted to unprofitable or speculative growth names, including early-stage software, biotechnology, and other high-cash-burn segments that occasionally dominate growth index performance.

The fund’s sector allocation and individual holdings shift based on how companies are scoring at any given time, but the philosophy remains constant: quality-tilted growth rather than momentum chasing. This positioning has meant FTC historically outperforms during periods when the market discounts valuation and prefers profitable firms, and underperforms during speculative rallies in unprofitable, high-momentum growth stocks.

Costs and liquidity

FTC trades on the NASDAQ with solid daily volume and reasonable bid-ask spreads, making it accessible to both retail and institutional investors. The expense ratio is reasonable for an actively screened, methodologically complex fund. Compared to a fully passive Russell 1000 Growth Index ETF, FTC costs more, but compared to traditional actively managed growth mutual funds, it is economical.

The growth-value value proposition

The fundamental bet underlying FTC is that an investor can do better by blending growth and value disciplines than by pure-play growth. This has proven true in some eras and false in others. During the 2000s, FTC benefited from the market’s return to profitability and value discipline after the dot-com bubble. During 2020–2021, unprofitable technology stocks surged and FTC lagged. The fund’s performance depends entirely on whether the market is currently rewarding or penalizing growth at reasonable valuations.

Risks and evaluation

FTC is not immune from general growth-stock risk: if the economy slows and growth companies’ earnings forecasts fall, the fund will decline alongside other growth portfolios. The AlphaDEX screen also carries its own blindspot risk — the methodology may systematically undervalue certain types of competitive advantage or may be slow to identify new growth themes that don’t fit traditional profitability metrics.

Investors evaluating FTC should examine its performance relative to a simple passive Russell 1000 Growth ETF over full market cycles, compare its sector and valuation characteristics to understand exactly where it differs, and review the prospectus to grasp the AlphaDEX scoring model. Historical drawdowns during growth downturns will show whether the quality overlay meaningfully reduced losses.